China BCT Pharmacy Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNBI research report →
Price Chart
About the company
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing.
- CEO
- Huitian Tang
- IPO
- 2010
- Employees
- 1,677
- HQ
- Liuzhou, CN
Get TickerSpark's AI analysis on CNBI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $686.78K
- P/E
- 0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
- Gross Margin
- 20.13%
- Op Margin
- 12.15%
- Net Margin
- 8.70%
- ROE
- 16.79%
- ROIC
- 11.56%
Latest fiscal year · YoY change
- Revenue
- $241.87M-6.1%
- Gross Profit
- $48.68M-21.2%
- Op Income
- $29.39M
- Net Income
- $21.05M-32.5%
- EPS
- $0.42-41.7%
- OCF Growth
- -86.9%
- FCF Growth
- -66.5%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -3.86
- RSI (14)
- 0
- Avg Volume
- 47
No earnings-call transcripts are available for CNBI yet.
- Free Float
- 0.5%
- Shares Outstanding
- 3.43B
- Float Shares
- 15.67M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 16, 11 | Tang Hui Tian | other | 1,245,000 |
| Dec 16, 11 | Tang Hui Tian | other | 762,500 |
| Dec 16, 11 | Choi Hon Keung Simon | other | 10,000 |
| Dec 16, 11 | CHIU MAN WAI JAMES | other | 10,000 |
| Dec 16, 11 | Chin Kam-Cheung | other | 10,000 |
| Jun 8, 11 | Chin Kam-Cheung | other | 10,000 |
| Dec 31, 11 | Chin Kam-Cheung | other | 0 |
| Dec 16, 11 | Zhang Xiaoyan | other | 830,000 |
| Dec 16, 11 | Zhang Xiaoyan | other | 762,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CNBI coverage
Recent articles, reports, and earnings notes.
No research on CNBI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNBI report →